This web site may not be supported by all mobile browsers.
Use the refresh button on your browser to make sure you have the latest information about special announcements on this page.
Our June 07, 2015 meeting will include a special guest speaker from Ipsen Biopharmaceutical to talk about Somatuline Depot (Lanreotide)
For more information, including location, click here.
The New Jersey Carcinoid Cancer NETwork has been serving the NJ community since 2001, when we started as the NJ Chapter of the Metro New York Carcinoid Support Group. When the metro group was formed, it was thought that because Carcinoid and other Neuroendocrine Tumors (NETs) were so rare, it would require a large geographic area to create a comprehensive group. With the advent of the increased awareness, in part due to support groups, we are now able to provide a more localized group to better serve everyone.
We hold in person meetings most months. Our meeting are far from pity parties. Instead we exchange information about diagnosis, treatment and our research and experiences with all types of NeuroEndocrine Tumors (NETs). We laugh more than we cry, more like a support group without the tissue boxes. At these meetings we can discuss details that would often be lost through any other means of communication other than face to face. Click here more details of those meetings.
Browse our Web site for more information about NJ Carcinoid Cancer NETwork. Please note that the website is a work in progress, so plan to check back for newly added material. If you have any questions or would like to speak with a NJ Carcinoid Cancer NETwork representative, please e-mail Pat at firstname.lastname@example.org or e-mail Jim at email@example.com or call 609-812-9294.
Our mission is to promote awareness of Carcinoid and other Neuroendocrine Tumors (NETs) and to provide shared information to patients, caregivers and medical professionals to assist them in managing their disease, provide treatment and diagnostic options that may not be common knowledge.
Canít make it to a meeting? Ask Us here